CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
CoEnzyme Q10drug
Likely dose
CoEnzyme Q10 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00720369
NCT00720369N/ACompleted
CompareCT.gov

Oral Administration of CoQ10 and Phosphorus-31 Magnetization Transfer Magnetic Resonance Spectroscopy in Geriatric Bipolar Disorder and Healthy Older Adults

Mclean Hospital·interventional·Posted Jul 22, 2008·Updated Jan 13, 2014

In Brief

A clinical study evaluating CoEnzyme Q10 for Bipolar Depression. Completed, enrolled 42 participants across 1 site.

Detailed Summary

We propose to study and compare measures of brain energy metabolism in geriatric bipolar individuals and healthy older adults. We would also like to investigate changes in brain energy metabolites and in vivo creatine kinase (CK) enzymatic activity associated with CoQ10 administration in older bipolar individuals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Depression
CountriesUnited States
CollaboratorsNational Alliance for Research on Schizophrenia and Depression

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 22, 2008
Enrollment StartJul 1, 2008
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.9 years ago

Interventions

CoEnzyme Q10drug

CoEnzyme Q10 with dosage range from 400 mg to 1200 mg per day